Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors


Cite item

Full Text

Abstract

Aim. The aim of the study was to determine causes of proton pump inhibitors (PPIs) inefficacy in some patients suffering from gastroesophageal reflux disease (GERD).
Material and methods. In our study of 154 GERD patients, 50 received omeprazole, 51 - lansoprazole and 53 - pantoprazole in a standard daily dose. GERD symptoms (heartburn and regurgitation) were scored by Likert scale; the patients' quality of life (SF-36) and their mental status (SMALL) were examined. Upper gastrointestinal endoscopy, 24-h intraesophageal pH monitoring, esophageal manometry and pharmacokinetic study were performed.
Results. The treatment with a standard dose of PPIs was ineffective in 21 (13.6%) patients. Causes of PPIs inefficacy in 4.5% patients were rapid PPI metabolism and in 9.1% - "driving gear" of symptoms formation related with psychic dysadaptation.

References

  1. Лазебник Л. Б., Машарова А. А., Бордин Д. С. и др. Результаты многоцентрового исследования "Эпидемиология Гастроэзофагеальной РЕфлюксной болезни в России" ("МЭГРЕ"). Тер. арх. 2011; 1: 45-50.
  2. Стандарты диагностики и лечения кислотозависимых и ассоциированных с Helicobacter pylori заболеваний (четвертое Московское соглашение). Экспер. и клин. гастроэнтерол. 2010; 5: 113-118.
  3. Vakil N., van Zanden S. V., Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am. J. Gastroenterol. 2006; 101: 1900-1920.
  4. Van Pinxteren B., Numan M. E., Bonis P. A. et al. Shortterm treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst. Rev. 2004; 4: CD002095.
  5. Holtmann G., Adam B., Liebregts T. Review article: the patient with gastro-oesophageal reflux disease-lifestyle advice and medication. Aliment Pharmacol Ther. 2004; 20 (Suppl. 8): 24-27.
  6. Rubenstein J. H., Nojkov B., Korsnes S. et al. Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2007; 26: 443-452.
  7. Пасечников В. Д., Пасечников Д. В. Как добиться максимальной эффективности медикаментозной терапии гастроэзофагеальной рефлюксной болезни. Фарматека 2008; 13: 68-72.
  8. Зайцев В. П. Вариант психологического теста MINI-MULT. Психол. журн. 1981; 3: 118-123.
  9. Личко А. Е. Методы психологической диагностики и коррекции в клинике. Л.; 1983.
  10. Новик А. А., Ионова Т. И. Руководство по исследованию качества жизни в медицине. СПб.: Издательский Дом "Нева"; М.: ОЛМА-ПРЕСС Звездный мир; 2002.
  11. Fass R., Shapiro M., Dekel R., Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment. Pharmacol. Ther. 2005; 22: 79-94.
  12. Fass R. Persistent heartburn in a patient on proton-pump inhibitor. Clin. Gastroenterol. Hepatol. 2008; 6: 393-400.
  13. Gunaratnam N. T., Jessup T. P., Inadomi J. M., Lascewski D. P. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2006; 23: 1473-1477.
  14. Bautista J. M., Wong W. M., Pulliam G. et al. The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications. Dig. Dis. Sci. 2005; 50: 1909-1915.
  15. Charbel S., Khandwala F., Vaezi M. F. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am. J. Gastroenterol. 2005; 100: 283-289.
  16. Mainie I., Tutuian R., Shay S. et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-1402.
  17. Zerbib F., Roman S., Ropert A. et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am. J. Gastroenterol. 2006; 101: 1956-1963.
  18. Jansson C., Nordenstedt H., Wallander M.-A. et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment. Pharmacol. Ther. 2007; 26: 683-691.
  19. Лазебник Л. Б. Изжога и гастроэзофагеальная рефлюксная болезнь: проблемы и решения. Тер. арх. 2008; 2: 5-11.
  20. Rohof W. O., Hirsch D. P., Boeckxstaens G. E. Pathophysiology and management of gastroesophageal reflux disease. Minerva Gastroenterol. Dietol. 2009; 55 (3): 289-300.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies